Natixis Advisors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,889
Closed -$206K 1475
2022
Q1
$206K Sell
10,889
-5,905
-35% -$150K ﹤0.01% 1413
2021
Q4
$589K Buy
16,794
+879
+6% +$28.6K ﹤0.01% 1224
2021
Q3
$583K Buy
15,915
+768
+5% +$30.2K ﹤0.01% 1189
2021
Q2
$595K Sell
15,147
-940
-6% -$27.1K ﹤0.01% 1190
2021
Q1
$454K Sell
16,087
-56
-0.3% -$1.79K ﹤0.01% 1179
2020
Q4
$517K Sell
16,143
-55
-0.3% -$1.69K ﹤0.01% 1117
2020
Q3
$523K Buy
16,198
+2,931
+22% +$91.4K ﹤0.01% 1045
2020
Q2
$366K Buy
+13,267
New +$288K ﹤0.01% 1103
2020
Q1
Sell
-10,104
Closed -$253K 1188
2019
Q4
$253K Buy
+10,104
New +$221K ﹤0.01% 1102

Other funds holding HCM

Natixis Advisors's HCM Position: Q2 2022 in Review

Natixis Advisors sold out of HUTCHMED (HCM) in Q2 2022, closing a stake of 10,889 shares — an estimated $206K sold.

Natixis Advisors first reported a position in HCM in Q4 2019 and held it in 9 quarters. The position peaked at $595K in Q2 2021. 116 funds tracked by Wall St. Rank hold HCM as of Q2 2022.

  • Natixis Advisors reported no remaining HUTCHMED position as of Q2 2022 after selling out during the quarter.
  • Natixis Advisors sold 10,889 HUTCHMED shares in Q2 2022, an estimated $206K.
  • Natixis Advisors first reported a position in HUTCHMED in Q4 2019 and held it in 9 quarters.
  • Natixis Advisors's HUTCHMED position peaked at $595K in Q2 2021.
  • 116 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2022.

Based on Natixis Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.